These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 21556526)

  • 1. Preclinical studies of gossypol in prostate carcinoma.
    Naik H; Petrylak D; Yagoda A; Lehr J; Akhtar A; Pienta K
    Int J Oncol; 1995 Jan; 6(1):209-13. PubMed ID: 21556526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro and in vivo study of antitumor effects of genistein on hormone refractory prostate cancer.
    Naik HR; Lehr JE; Pienta KJ
    Anticancer Res; 1994; 14(6B):2617-9. PubMed ID: 7872690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (-)-Gossypol reduces invasiveness in metastatic prostate cancer cells.
    Huang YW; Wang LS; Dowd MK; Wan PJ; Lin YC
    Anticancer Res; 2009 Jun; 29(6):2179-88. PubMed ID: 19528479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative and antimetastatic effects of gossypol on Dunning prostate cell-bearing Copenhagen rats.
    Chang CJ; Ghosh PK; Hu YF; Brueggemeier RW; Lin YC
    Res Commun Chem Pathol Pharmacol; 1993 Mar; 79(3):293-312. PubMed ID: 8480076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of gossypol on the invasiveness of MAT-LyLu cells and MAT-LyLu cells from the metastasized lungs of MAT-LyLu-bearing Copenhagen rats.
    Jiang J; Kulp SK; Sugimoto Y; Liu S; Lin YC
    Anticancer Res; 2000; 20(6B):4591-7. PubMed ID: 11205308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling of angiogenic cytokines produced by hormone- and drug-refractory prostate cancer cell lines, PC-3 and DU-145 before and after treatment with gossypol.
    Karaca B; Kucukzeybek Y; Gorumlu G; Erten C; Gul MK; Cengiz E; Atmaca H; Uzunoglu S; Sanli UA; Karabulut B; Uslu R
    Eur Cytokine Netw; 2008 Dec; 19(4):176-84. PubMed ID: 19103523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gossypol inhibits the growth of MAT-LyLu prostate cancer cells by modulation of TGFbeta/Akt signaling.
    Jiang J; Ye W; Lin YC
    Int J Mol Med; 2009 Jul; 24(1):69-75. PubMed ID: 19513537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibitory effects of gossypol on human prostate cancer cells-PC3 are associated with transforming growth factor beta1 (TGFbeta1) signal transduction pathway.
    Jiang J; Sugimoto Y; Liu S; Chang HL; Park KY; Kulp SK; Lin YC
    Anticancer Res; 2004; 24(1):91-100. PubMed ID: 15015581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of gossypol on O2 consumption and CO2 production in human prostate cancer cells.
    Jiang J; Ghosh PK; Kulp SK; Sugimoto Y; Liu S; Czekajewski J; Chang HL; Lin YC
    Anticancer Res; 2002; 22(3):1491-6. PubMed ID: 12168828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral cyclophosphamide and oral hydroxyurea in the treatment of hormone refractory prostate cancer in rats.
    Naik H; Lehr J; Akhtar A; Pienta K
    Anticancer Res; 1994; 14(6B):2681-4. PubMed ID: 7872701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro anti-prostate cancer and ex vivo antiangiogenic activity of Vernonia guineensis Benth. (Asteraceae) tuber extracts.
    Toyang NJ; Wabo HK; Ateh EN; Davis H; Tane P; Kimbu SF; Sondengam LB; Bryant J
    J Ethnopharmacol; 2012 Jun; 141(3):866-71. PubMed ID: 22465590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin.
    Pienta KJ; Naik H; Akhtar A; Yamazaki K; Replogle TS; Lehr J; Donat TL; Tait L; Hogan V; Raz A
    J Natl Cancer Inst; 1995 Mar; 87(5):348-53. PubMed ID: 7853416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can homeopathic treatment slow prostate cancer growth?
    Jonas WB; Gaddipati JP; Rajeshkumar NV; Sharma A; Thangapazham RL; Warren J; Singh AK; Ives JA; Olsen C; Mog SR; Maheshwari RK
    Integr Cancer Ther; 2006 Dec; 5(4):343-9. PubMed ID: 17101763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice.
    Suy S; Mitchell JB; Samuni A; Mueller S; Kasid U
    Cancer; 2005 Mar; 103(6):1302-13. PubMed ID: 15685617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
    Getzenberg RH; Light BW; Lapco PE; Konety BR; Nangia AK; Acierno JS; Dhir R; Shurin Z; Day RS; Trump DL; Johnson CS
    Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of castanospermine on the metastatic properties of prostate cancer cells.
    Yee CS; Schwab ED; Lehr JE; Quigley M; Pienta KJ
    Anticancer Res; 1997; 17(5A):3659-63. PubMed ID: 9413219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of protein kinase C-zeta (PKC-zeta) inhibits invasive and metastatic abilities of Dunning R-3327 MAT-LyLu rat prostate cancer cells.
    Powell CT; Gschwend JE; Fair WR; Brittis NJ; Stec D; Huryk R
    Cancer Res; 1996 Sep; 56(18):4137-41. PubMed ID: 8797581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profiles of voltage-gated Na(+) channel alpha-subunit genes in rat and human prostate cancer cell lines.
    Diss JK; Archer SN; Hirano J; Fraser SP; Djamgoz MB
    Prostate; 2001 Aug; 48(3):165-78. PubMed ID: 11494332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo studies on antitumor effects of gossypol on human stomach adenocarcinoma (AGS) cell line and MNNG induced experimental gastric cancer.
    Gunassekaran GR; Priya DK; Gayathri R; Sakthisekaran D
    Biochem Biophys Res Commun; 2011 Aug; 411(4):661-6. PubMed ID: 21782799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-carcinogenic and anti-metastatic properties of indole-3-carbinol in prostate cancer.
    Garikapaty VP; Ashok BT; Chen YG; Mittelman A; Iatropoulos M; Tiwari RK
    Oncol Rep; 2005 Jan; 13(1):89-93. PubMed ID: 15583807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.